Practice note 17 (PN17) company, Biosis Group plans to ramp up prediction to more than 60 per cent within 3 years from less than 50 per cent currently at its pharmaceutical factory in Penang. This is in line with its expansion to new export markets in Europe, India And the Middle East.<br /><br />Astro AWANI LIVE http://www.astroawani.com/videos/live<br />Subscibe to NJOI AWANI https://www.youtube.com/njoiawani<br />Follow us on Website http://www.astroawani.com<br />Like us on Facebook https://www.facebook.com/astroawani<br />Follow us on Twitter https://twitter.com/501Awani<br />Follow us on Instagram http://instagram.com/501awani
